[Recent developments in high-dose immunoglobulin therapy: therapeutic plasma exchange, autoimmune diseases].
D019867:Anti-Glomerular Basement Membrane Disease / Q000628:therapy; D001323:Autoantibodies / Q000096:biosynthesis; D001327:Autoimmune Diseases / Q000628:therapy*; D004306:Dose-Response Relationship, Immunologic; D005246:Feedback; D006801:Humans; D007105:Immune Complex Diseases / Q000628:therapy; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000008:administration & dosage; D007136:Immunoglobulins / Q000008:administration & dosage*; D008180:Lupus Erythematosus, Systemic / Q000628:therapy; D009157:Myasthenia Gravis / Q000628:therapy; D010951:Plasma Exchange; D010956:Plasmapheresis; D011696:Purpura, Thrombocytopenic / Q000628:therapy
D001323:Autoantibodies; D007074:Immunoglobulin G; D007136:Immunoglobulins
Neue Indikationsgebiete zur hochdosierten Immunglobulintherapie: Therapeutischer Plasmaaustausch, Autoimmunopathien.